日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and radiological outcomes of directed treatment transitions from Gilenya(®) to generic fingolimod

从吉列尼亚® (Gilenya®) 过渡到通用芬戈莫德的定向治疗方案的临床和放射学结果

Patel, Mahi A; Punnen, Tom G; Shan, Kevin S; McCreary, Morgan C; Wright, Crystal M; Munoz, Shanan B; Hardeman, Paula; Burgess, Katy W; Greenberg, Benjamin M; Horton, Lindsay A; Sguigna, Peter V; Tardo, Lauren M; Stüve, Olaf; Okuda, Darin T

Detection of Varicella Zoster Virus Reactivation in Cerebrospinal Fluid in Ischemic Stroke or Transient Ischemic Attack

缺血性卒中或短暂性脑缺血发作患者脑脊液中水痘-带状疱疹病毒再激活的检测

Li, Wenyang; Sguigna, Peter; Rupareliya, Chintan; Subramanian, Suriya; Salahuddin, Hisham; Husari, Khalil S; Moore, William; Johnson, Mark; Magadan, Alejandro; Grose, Charles; Nijhawan, Ank E; Shang, Ty

Correction: Evidence of brain target engagement in Parkinson's disease and multiple sclerosis by the investigational nanomedicine, CNM- Au8, in the REPAIR phase 2 clinical trials

更正:在 REPAIR II 期临床试验中,研究性纳米药物 CNM-Au8 显示出与帕金森病和多发性硬化症脑靶点结合的证据

Ren, Jimin; Dewey, Richard B 3rd; Rynders, Austin; Evan, Jacob; Evan, Jeremy; Ligozio, Shelia; Ho, Karen S; Sguigna, Peter V; Glanzman, Robert; Hotchkin, Michael T; Dewey, Richard B Jr; Greenberg, Benjamin M

Cladribine tablets after treatment with natalizumab (CLADRINA) - rationale and design

克拉屈滨片在接受那他珠单抗治疗后(CLADRINA)——原理和设计

Sguigna, Peter V; Hussain, Rehana Z; Okai, Annette; Blackburn, Kyle M; Tardo, Lauren; Madinawala, Mariam; Korich, Julie; Lebson, Lori A; Kaplan, Jeffrey; Salter, Amber; Manouchehri, Navid; Stuve, Olaf

Design and Implementation of a Brief, Self-Directed Course on Immunotherapy Best Practices for Neurology Trainees

为神经病学培训生设计和实施关于免疫疗法最佳实践的简短自学课程

Blackburn, Kyle M; Sguigna, Peter V; Tardo, Lauren; Khan, Shaida; Vernino, Steven; Phillips, Lauren

Evidence of brain target engagement in Parkinson's disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials

REPAIR II 期临床试验中,研究性纳米药物 CNM-Au8 显示出与帕金森病和多发性硬化症脑靶点结合的证据

Ren, Jimin; Dewey, Richard B 3rd; Rynders, Austin; Evan, Jacob; Evan, Jeremy; Ligozio, Shelia; Ho, Karen S; Sguigna, Peter V; Glanzman, Robert; Hotchkin, Michael T; Dewey, Richard B Jr; Greenberg, Benjamin M

A narrative review of neuro-ophthalmologic disease in African Americans and Hispanics with multiple sclerosis

对患有多发性硬化症的非裔美国人和西班牙裔美国人的神经眼科疾病进行叙述性综述

Tardo, Lauren; Salter, Amber; Truong-Le, Melanie; Horton, Lindsay; Blackburn, Kyle M; Sguigna, Peter V

Disease associations of excessive daytime sleepiness in multiple sclerosis: A prospective study

多发性硬化症患者白天过度嗜睡的疾病关联:一项前瞻性研究

Sguigna, Peter V; Toranian, Sabeen; Tardo, Lauren M; Blackburn, Kyle M; Horton, Lindsay A; Conger, Darrel; Meltzer, Ethan; Hogan, R Nick; McCreary, Morgan C; Zee, Phyllis C; Takahashi, Joseph S; Greenberg, Benjamin M

A cross-sectional natural history study of aspartylglucosaminuria

天冬氨酰葡糖胺尿症的横断面自然史研究

Goodspeed, Kimberly; Horton, Daniel; Lowden, Andrea; Sguigna, Peter V; Booth, Timothy; Wang, Zhiyue J; Edgar, Veronica Bordes

Application of the International Interocular Difference Thresholds into Practice: Localising the Patient Experience

国际眼间差异阈值在实践中的应用:关注患者体验

Sguigna, Peter V; Tardo, Lauren M; Blackburn, Kyle M; Horton, Lindsay A; Conger, Darrel L; Hogan, R Nick; McCreary, Morgan C; Greenberg, Benjamin M